231 related articles for article (PubMed ID: 25388799)
1. Circadian clock genes and risk of fatal prostate cancer.
Markt SC; Valdimarsdottir UA; Shui IM; Sigurdardottir LG; Rider JR; Tamimi RM; Batista JL; Haneuse S; Flynn-Evans E; Lockley SW; Czeisler CA; Stampfer MJ; Launer L; Harris T; Smith AV; Gudnason V; Lindstrom S; Kraft P; Mucci LA
Cancer Causes Control; 2015 Jan; 26(1):25-33. PubMed ID: 25388799
[TBL] [Abstract][Full Text] [Related]
2. Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
Gu F; Zhang H; Hyland PL; Berndt S; Gapstur SM; Wheeler W; Ellipse Consortium T; Amos CI; Bezieau S; Bickeböller H; Brenner H; Brennan P; Chang-Claude J; Conti DV; Doherty JA; Gruber SB; Harrison TA; Hayes RB; Hoffmeister M; Houlston RS; Hung RJ; Jenkins MA; Kraft P; Lawrenson K; McKay J; Markt S; Mucci L; Phelan CM; Qu C; Risch A; Rossing MA; Wichmann HE; Shi J; Schernhammer E; Yu K; Landi MT; Caporaso NE
Int J Cancer; 2017 Nov; 141(9):1794-1802. PubMed ID: 28699174
[TBL] [Abstract][Full Text] [Related]
3. Machine learning analyses reveal circadian clock features predictive of anxiety among UK biobank participants.
Ventresca C; Mohamed W; Russel WA; Ay A; Ingram KK
Sci Rep; 2023 Dec; 13(1):22304. PubMed ID: 38102312
[TBL] [Abstract][Full Text] [Related]
4. Circadian pathway genes in relation to glioma risk and outcome.
Madden MH; Anic GM; Thompson RC; Nabors LB; Olson JJ; Browning JE; Monteiro AN; Egan KM
Cancer Causes Control; 2014 Jan; 25(1):25-32. PubMed ID: 24135790
[TBL] [Abstract][Full Text] [Related]
5. Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment.
Sanchez A; Schoenfeld JD; Nguyen PL; Fiorentino M; Chowdhury D; Stampfer MJ; Sesso HD; Giovannucci E; Mucci LA; Shui IM
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):197-201. PubMed ID: 26926928
[TBL] [Abstract][Full Text] [Related]
6. Urinary 6-sulfatoxymelatonin Levels and Prostate Cancer Risk among Men in the Multiethnic Cohort.
Vaselkiv JB; Cheng I; Chowdhury-Paulino IM; Gonzalez-Feliciano AG; Wilkens LR; Hauksdóttir AM; Eiriksdottir G; Le Marchand L; Haiman CA; Valdimarsdóttir U; Mucci LA; Markt SC
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):688-691. PubMed ID: 34937795
[TBL] [Abstract][Full Text] [Related]
7. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
[TBL] [Abstract][Full Text] [Related]
8. Genomic rearrangements in prostate cancer.
Barbieri CE; Rubin MA
Curr Opin Urol; 2015 Jan; 25(1):71-6. PubMed ID: 25393273
[TBL] [Abstract][Full Text] [Related]
9. WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer.
Kiss Z; Ghosh PM
Endocr Relat Cancer; 2016 Nov; 23(11):T123-T134. PubMed ID: 27660402
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.
Alumkal JJ; Slottke R; Schwartzman J; Cherala G; Munar M; Graff JN; Beer TM; Ryan CW; Koop DR; Gibbs A; Gao L; Flamiatos JF; Tucker E; Kleinschmidt R; Mori M
Invest New Drugs; 2015 Apr; 33(2):480-9. PubMed ID: 25431127
[TBL] [Abstract][Full Text] [Related]
11. Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study.
Markt SC; Flynn-Evans EE; Valdimarsdottir UA; Sigurdardottir LG; Tamimi RM; Batista JL; Haneuse S; Lockley SW; Stampfer M; Wilson KM; Czeisler CA; Rider JR; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):302-8. PubMed ID: 26677208
[TBL] [Abstract][Full Text] [Related]
12. The aging clock and circadian control of metabolism and genome stability.
Belancio VP; Blask DE; Deininger P; Hill SM; Jazwinski SM
Front Genet; 2014; 5():455. PubMed ID: 25642238
[TBL] [Abstract][Full Text] [Related]
13. Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice.
Billing A; Buchner A; Stief C; Roosen A
World J Urol; 2015 Jul; 33(7):923-8. PubMed ID: 25432525
[TBL] [Abstract][Full Text] [Related]
14. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer.
Kvorning Ternov K; Krag Jakobsen A; Bratt O; Ahlgren G
Scand J Urol; 2015 Apr; 49(2):115-9. PubMed ID: 25428754
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.
Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K
Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750
[TBL] [Abstract][Full Text] [Related]
16. SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines.
Bernetich M; Oliai C; Lanciano R; Hanlon A; Lamond J; Arrigo S; Yang J; Good M; Feng J; Brown R; Garber B; Mooreville M; Brady LW
Front Oncol; 2014; 4():312. PubMed ID: 25426447
[TBL] [Abstract][Full Text] [Related]
17. Robot assisted radical prostatectomy: the new standard?
Laviana AA; Williams SB; King ED; Chuang RJ; Hu JC
Minerva Urol Nefrol; 2015 Mar; 67(1):47-53. PubMed ID: 25424387
[TBL] [Abstract][Full Text] [Related]
18. How accurate is multiparametric MR imaging in evaluation of prostate cancer volume?
Bratan F; Melodelima C; Souchon R; Hoang Dinh A; Mège-Lechevallier F; Crouzet S; Colombel M; Gelet A; Rouvière O
Radiology; 2015 Apr; 275(1):144-54. PubMed ID: 25423145
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate intake, glycemic index and prostate cancer risk.
Vidal AC; Williams CD; Allott EH; Howard LE; Grant DJ; McPhail M; Sourbeer KN; Hwa LP; Boffetta P; Hoyo C; Freedland SJ
Prostate; 2015 Mar; 75(4):430-9. PubMed ID: 25417840
[TBL] [Abstract][Full Text] [Related]
20. Margin involvement at prostatectomy for clinically localized prostate cancer: does a low-risk group exist?
Watkins JM; Laszewski M; Watkins PL; Dufan TA; Adducci C
Pract Radiat Oncol; 2015; 5(1):e31-6. PubMed ID: 25413418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
